首页> 外文期刊>Radiation Research: Official Organ of the Radiation Research Society >Evaluation of the radiosensitivity of the oxygenated tumor cell fractions in quiescent cell populations within solid tumors
【24h】

Evaluation of the radiosensitivity of the oxygenated tumor cell fractions in quiescent cell populations within solid tumors

机译:实体瘤内静态细胞群体中氧化肿瘤细胞部分的放射敏感性评估

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Labeling of all proliferating cells in C57BL/6J mice bearing EL4 tumors was achieved by continuous administration of 5-bromo-2′-deoxyuridine (BrdU). Tumors were irradiated with γ rays at a high dose rate or a reduced dose rate at 1 h after the administration of pimonidazole. Assessment of the responses of quiescent and total (proliferating quiescent) cell populations were based on the frequencies of micronucleation and apoptosis using immunofluorescence staining for BrdU. The response of the pimonidazole-unlabeled tumor cell fractions was assessed by means of apoptosis frequency using immunofluorescence staining for pimonidazole. The total cell fraction that was not labeled with pimonidazole showed significantly enhanced radiosensitivity. However, a significantly greater decrease in radiosensitivity, evaluated using a delayed assay or a decrease in radiation dose rate, was observed in the quiescent cell compared with the total cell population. Overall, the quiescent cell population showed significantly greater radioresistance and capacity to recover from radiation-induced damage than the total tumor cell population. Thus we believe that the subfraction of the quiescent tumor cell population that was not labeled with pimonidazole and that was probably oxygenated is a critical target in the control of solid tumors.
机译:通过连续施用5-溴-2'-脱氧尿苷(BrdU),可以对带有EL4肿瘤的C57BL / 6J小鼠的所有增殖细胞进行标记。吡莫硝唑给药后1小时,以高剂量率或降低剂量率的γ射线照射肿瘤。使用BrdU免疫荧光染色基于微核化和细胞凋亡的频率来评估静态和总体(增殖静态)细胞群体的反应。吡莫硝唑未标记的肿瘤细胞级分的反应通过对吡莫尼唑进行免疫荧光染色的细胞凋亡频率进行评估。未用吡莫硝唑标记的总细胞部分显示出显着增强的放射敏感性。然而,与总细胞群体相比,在静止细胞中观察到使用延迟测定评估的放射敏感性明显降低或辐射剂量率降低。总体而言,静态细胞群体显示出比总肿瘤细胞群体更大的抗辐射能力和从辐射诱发的损害中恢复的能力。因此,我们认为,未用吡莫硝唑标记并且可能被氧化的静态肿瘤细胞群的亚部分是控制实体瘤的关键目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号